Metraipolis › archive › dc_43efd47bb0e4

Recurrent hypofibrinogenemia after reduced-dose tocilizumab rechallenge in rheumatoid arthritis: a case report — Europe PMC PMID:42973881

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42973881
DOI
10.3389/fphar.2026.1981054
License (as archived)
solo-consultazione
Archived
2026-11-07T17:05:18.540Z
SHA-256 of the archived text
eb6cb1cb6db1bc44a4aedb9fd418d26d3b2a904a9eeaf8a78c8adaa5f3900777
Stable URL of this page
https://metraipolis.com/documento/dc_43efd47bb0e4

How to cite

Recurrent hypofibrinogenemia after reduced-dose tocilizumab rechallenge in rheumatoid arthritis: a case report — Europe PMC PMID:42973881 — Europe PMC (en), https://europepmc.org/article/MED/42973881 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_43efd47bb0e4 (Metraipolis archive dc_43efd47bb0e4, sha256 eb6cb1cb6db1bc44a4aedb9fd418d26d3b2a904a9eeaf8a78c8adaa5f3900777)
BibTeX
@misc{dc43efd47bb0e4,
  title = {Recurrent hypofibrinogenemia after reduced-dose tocilizumab rechallenge in rheumatoid arthritis: a case report — Europe PMC PMID:42973881},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42973881},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_43efd47bb0e4; sha256 eb6cb1cb6db1bc44a4aedb9fd418d26d3b2a904a9eeaf8a78c8adaa5f3900777},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42973881. Agents can read the archived copy with the MCP tool read_document.